WINNINGHAM RICK E (Chief Executive Officer) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/24/2026ACC: 0001302443-26-000012
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-20.03K
Net shares
Net seller
$339.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
20.03K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−20.03K
Price / share
$16.95
Trade value
$339.58K
% of position
1.2%
8/20/2026
1.63M→1.61M
Total
Net shares
−20.03K
Net value
-$339.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/20/2026 | F · Tax Withholding | −20.03K | $16.95 | $339.58K | 1.2% | 1.63M | 1.61M |
| Total | −20.03K | -$339.58K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Ordinary Shares
IndirectShares owned92.57K
Ordinary Shares
IndirectShares owned23.40K
Total
115.97K indirect115.97K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 92.57K | Indirect |
| Ordinary Shares | 23.40K | Indirect |
| Total | 115.97K | 115.97K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported